{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:06:12Z","timestamp":1768003572438,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13104-017-3086-7","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T08:35:48Z","timestamp":1513845348000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Risk factors for bone loss in patients with rheumatoid arthritis treated with biologic disease-modifying anti-rheumatic drugs"],"prefix":"10.1186","volume":"10","author":[{"given":"Hiroki","family":"Tawaratsumida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Setoguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiya","family":"Arishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Ohtsubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Akimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Ishidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Taketomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiko","family":"Sunahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Setsuro","family":"Komiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,21]]},"reference":[{"issue":"2","key":"3086_CR1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/art.10996","volume":"49","author":"MC Lodder","year":"2003","unstructured":"Lodder MC, Haugeberg G, Lems WF, Uhlig T, Orstavik RE, Kostense PJ, Dijkmans BA, Kvien TK, Woolf AD. Radiographic damage associated with low bone mineral density and vertebral deformities in rheumatoid arthritis: the Oslo-Truro-Amsterdam (OSTRA) collaborative study. Arthritis Rheum. 2003;49(2):209\u201315.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3086_CR2","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-Y","volume":"43","author":"G Haugeberg","year":"2000","unstructured":"Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum. 2000;43(3):522\u201330.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"3086_CR3","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.autrev.2013.03.015","volume":"12","author":"T Dimitroulas","year":"2013","unstructured":"Dimitroulas T, Nikas SN, Trontzas P, Kitas GD. Biologic therapies and systemic bone loss in rheumatoid arthritis. Autoimmun Rev. 2013;12(10):958\u201366.","journal-title":"Autoimmun Rev"},{"issue":"12","key":"3086_CR4","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1136\/ard.2010.148015","volume":"70","author":"P Emery","year":"2011","unstructured":"Emery P, Dorner T. Optimising treatment in rheumatoid arthritis: a review of potential biological markers of response. Ann Rheum Dis. 2011;70(12):2063\u201370.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3086_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000165777","volume":"83","author":"SP Venkateshan","year":"2009","unstructured":"Venkateshan SP, Sidhu S, Malhotra S, Pandhi P. Efficacy of biologicals in the treatment of rheumatoid arthritis. A meta-analysis. Pharmacology. 2009;83(1):1\u20139.","journal-title":"Pharmacology"},{"issue":"3","key":"3086_CR6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/BOR.0b013e328329f84f","volume":"21","author":"E Keystone","year":"2009","unstructured":"Keystone E. Recent concepts in the inhibition of radiographic progression with biologics. Curr Opin Rheumatol. 2009;21(3):231\u20137.","journal-title":"Curr Opin Rheumatol"},{"issue":"13","key":"3086_CR7","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.2174\/13894501113149990176","volume":"14","author":"R Sakthiswary","year":"2013","unstructured":"Sakthiswary R, Das S. The effects of TNF alpha antagonist therapy on bone metabolism in rheumatoid arthritis: a systematic review. Curr Drug Targets. 2013;14(13):1552\u20137.","journal-title":"Curr Drug Targets"},{"issue":"9","key":"3086_CR8","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1007\/s00198-013-2321-x","volume":"24","author":"JP Roussy","year":"2013","unstructured":"Roussy JP, Bessette L, Bernatsky S, Rahme E, Lachaine J. Biologic disease-modifying anti-rheumatic drugs and the risk of non-vertebral osteoporotic fractures in patients with rheumatoid arthritis aged 50\u00a0years and over. Osteoporos Int. 2013;24(9):2483\u201392.","journal-title":"Osteoporos Int"},{"issue":"7","key":"3086_CR9","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/acr.21937","volume":"65","author":"VK Kawai","year":"2013","unstructured":"Kawai VK, Grijalva CG, Arbogast PG, Curtis JR, Solomon DH, Delzell E, Chen L, Ouellet-Hellstrom R, Herrinton L, Liu L, et al. Initiation of tumor necrosis factor alpha antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseases. Arthritis Care Res. 2013;65(7):1085\u201394.","journal-title":"Arthritis Care Res"},{"issue":"4","key":"3086_CR10","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00198-010-1462-4","volume":"22","author":"CB Confavreux","year":"2011","unstructured":"Confavreux CB, Chapurlat RD. Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis. Osteoporos Int. 2011;22(4):1023\u201336.","journal-title":"Osteoporos Int"},{"issue":"7","key":"3086_CR11","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/ard.2008.091264","volume":"68","author":"M Hoff","year":"2009","unstructured":"Hoff M, Kvien TK, Kalvesten J, Elden A, Haugeberg G. Adalimumab therapy reduces hand bone loss in early rheumatoid arthritis: explorative analyses from the PREMIER study. Ann Rheum Dis. 2009;68(7):1171\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"3086_CR12","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1136\/ard.2008.106484","volume":"68","author":"G Haugeberg","year":"2009","unstructured":"Haugeberg G, Conaghan PG, Quinn M, Emery P. Bone loss in patients with active early rheumatoid arthritis: infliximab and methotrexate compared with methotrexate treatment alone. Explorative analysis from a 12-month randomised, double-blind, placebo-controlled study. Ann Rheum Dis. 2009;68(12):1898\u2013901.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3086_CR13","first-page":"663","volume":"2","author":"H Marotte","year":"2008","unstructured":"Marotte H, Miossec P. Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNFalpha therapy. Biologics. 2008;2(4):663\u20139.","journal-title":"Biologics"},{"issue":"7","key":"3086_CR14","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1172\/JCI119333","volume":"99","author":"P Ammann","year":"1997","unstructured":"Ammann P, Rizzoli R, Bonjour JP, Bourrin S, Meyer JM, Vassalli P, Garcia I. Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. J Clin Investig. 1997;99(7):1699\u2013703.","journal-title":"J Clin Investig"},{"issue":"9","key":"3086_CR15","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1002\/art.27580","volume":"62","author":"T Neogi","year":"2010","unstructured":"Neogi T, Aletaha D, Silman AJ, Naden RL, Felson DT, Aggarwal R, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, et al. The 2010 American College of Rheumatology\/European League Against Rheumatism classification criteria for rheumatoid arthritis: phase 2 methodological report. Arthritis Rheum. 2010;62(9):2582\u201391.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"3086_CR16","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/rheumatology\/keh297","volume":"43","author":"J Fransen","year":"2004","unstructured":"Fransen J, Creemers MC, Van Riel PL. Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology. 2004;43(10):1252\u20135.","journal-title":"Rheumatology"},{"issue":"3","key":"3086_CR17","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/ard.2011.149765","volume":"70","author":"DT Felson","year":"2011","unstructured":"Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J, Aletaha D, Allaart CF, Bathon J, Bombardieri S, et al. American College of Rheumatology\/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis. 2011;70(3):404\u201313.","journal-title":"Ann Rheum Dis"},{"key":"3086_CR18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12891-015-0732-x","volume":"16","author":"K Takahashi","year":"2015","unstructured":"Takahashi K, Setoguchi T, Tawaratsumida H, Arishima Y, Tominaga H, Ishidou Y, Nagano S, Shigemizu S, Aoki N, Akimoto M, et al. Risk of low bone mineral density in patients with rheumatoid arthritis treated with biologics. BMC Musculoskelet Disord. 2015;16:269.","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"3086_CR19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00774-004-0596-x","volume":"23","author":"H Nawata","year":"2005","unstructured":"Nawata H, Soen S, Takayanagi R, Tanaka I, Takaoka K, Fukunaga M, Matsumoto T, Suzuki Y, Tanaka H, Fujiwara S, et al. Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004). J Bone Miner Metab. 2005;23(2):105\u20139.","journal-title":"J Bone Miner Metab"},{"issue":"4","key":"3086_CR20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00774-014-0586-6","volume":"32","author":"Y Suzuki","year":"2014","unstructured":"Suzuki Y, Nawata H, Soen S, Fujiwara S, Nakayama H, Tanaka I, Ozono K, Sagawa A, Takayanagi R, Tanaka H, et al. Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research: 2014 update. J Bone Miner Metab. 2014;32(4):337\u201350.","journal-title":"J Bone Miner Metab"},{"issue":"6","key":"3086_CR21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s007740170001","volume":"19","author":"H Orimo","year":"2001","unstructured":"Orimo H, Hayashi Y, Fukunaga M, Sone T, Fujiwara S, Shiraki M, Kushida K, Miyamoto S, Soen S, Nishimura J, et al. Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab. 2001;19(6):331\u20137.","journal-title":"J Bone Miner Metab"},{"issue":"3","key":"3086_CR22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00774-013-0447-8","volume":"31","author":"S Soen","year":"2013","unstructured":"Soen S, Fukunaga M, Sugimoto T, Sone T, Fujiwara S, Endo N, Gorai I, Shiraki M, Hagino H, Hosoi T, et al. Diagnostic criteria for primary osteoporosis: year 2012 revision. J Bone Miner Metab. 2013;31(3):247\u201357.","journal-title":"J Bone Miner Metab"},{"issue":"12","key":"3086_CR23","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s00198-012-2093-8","volume":"23","author":"A Diez-Perez","year":"2012","unstructured":"Diez-Perez A, Adachi JD, Agnusdei D, Bilezikian JP, Compston JE, Cummings SR, Eastell R, Eriksen EF, Gonzalez-Macias J, Liberman UA, et al. Treatment failure in osteoporosis. Osteoporos Int. 2012;23(12):2769\u201374.","journal-title":"Osteoporos Int"},{"issue":"10","key":"3086_CR24","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1007\/s00198-016-3640-5","volume":"27","author":"M Shiraki","year":"2016","unstructured":"Shiraki M, Ueda S, Sugimoto T, Kuroda T, Nakamura T. Treatment responses with once-weekly teriparatide therapy for osteoporosis. Osteoporos Int. 2016;27(10):3057\u201362.","journal-title":"Osteoporos Int"},{"issue":"3","key":"3086_CR25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.healthpol.2013.04.011","volume":"112","author":"KE Fischer","year":"2013","unstructured":"Fischer KE, Rogowski WH, Leidl R, Stollenwerk B. Transparency vs. closed-door policy: do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysis. Health Policy. 2013;112(3):187\u201396.","journal-title":"Health Policy"},{"issue":"2","key":"3086_CR26","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s10067-002-8274-7","volume":"21","author":"K Shibuya","year":"2002","unstructured":"Shibuya K, Hagino H, Morio Y, Teshima R. Cross-sectional and longitudinal study of osteoporosis in patients with rheumatoid arthritis. Clin Rheumatol. 2002;21(2):150\u20138.","journal-title":"Clin Rheumatol"},{"issue":"7\u20139","key":"3086_CR27","first-page":"451","volume":"64","author":"B Cortet","year":"1997","unstructured":"Cortet B, Flipo RM, Blanckaert F, Duquesnoy B, Marchandise X, Delcambre B. Evaluation of bone mineral density in patients with rheumatoid arthritis. Influence of disease activity and glucocorticoid therapy. Rev Rhum Engl Ed. 1997;64(7\u20139):451\u20138.","journal-title":"Rev Rhum Engl Ed"},{"issue":"1","key":"3086_CR28","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/art.22294","volume":"56","author":"F Vries De","year":"2007","unstructured":"De Vries F, Bracke M, Leufkens HG, Lammers JW, Cooper C, Van Staa TP. Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum. 2007;56(1):208\u201314.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"3086_CR29","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200108","volume":"13","author":"TP Staa van","year":"2002","unstructured":"van Staa TP, Leufkens HG, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int. 2002;13(10):777\u201387.","journal-title":"Osteoporos Int"},{"issue":"3","key":"3086_CR30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00223-006-0019-1","volume":"79","author":"TP Staa van","year":"2006","unstructured":"van Staa TP. The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis. Calcif Tissue Int. 2006;79(3):129\u201337.","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"3086_CR31","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s00774-015-0716-9","volume":"35","author":"Y Mori","year":"2017","unstructured":"Mori Y, Kuwahara Y, Chiba S, Kogre A, Baba K, Kamimura M, Itoi E. Bone mineral density of postmenopausal women with rheumatoid arthritis depends on disease duration regardless of treatment. J Bone Miner Metab. 2017;35(1):52\u20137.","journal-title":"J Bone Miner Metab."},{"issue":"1","key":"3086_CR32","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/BOR.0000000000000007","volume":"26","author":"A Kleyer","year":"2014","unstructured":"Kleyer A, Schett G. Arthritis and bone loss: a hen and egg story. Curr Opin Rheumatol. 2014;26(1):80\u20134.","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"3086_CR33","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1136\/annrheumdis-2012-203171","volume":"73","author":"TW Jensen","year":"2014","unstructured":"Jensen TW, Hansen MS, Horslev-Petersen K, Hyldstrup L, Abrahamsen B, Langdahl B, Zerahn B, Podenphant J, Stengaard-Petersen K, Junker P, et al. Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial. Ann Rheum Dis. 2014;73(6):1123\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3086_CR34","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/rheumatology\/kes320","volume":"52","author":"CL Krieckaert","year":"2013","unstructured":"Krieckaert CL, Nurmohamed MT, Wolbink G, Lems WF. Changes in bone mineral density during long-term treatment with adalimumab in patients with rheumatoid arthritis: a cohort study. Rheumatology. 2013;52(3):547\u201353.","journal-title":"Rheumatology"},{"issue":"3","key":"3086_CR35","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1186\/ar2219","volume":"9","author":"H Marotte","year":"2007","unstructured":"Marotte H, Pallot-Prades B, Grange L, Gaudin P, Alexandre C, Miossec P. A 1-year case\u2013control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab. Arthritis Res Ther. 2007;9(3):R61.","journal-title":"Arthritis Res Ther"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-017-3086-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T08:35:56Z","timestamp":1513845356000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-017-3086-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3086"],"URL":"https:\/\/doi.org\/10.1186\/s13104-017-3086-7","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"765"}}